GoodRx Holdings
GDRX
147 hedge funds and large institutions have $739M invested in GoodRx Holdings in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 45 reducing their positions, and 34 closing their positions.
103% more call options, than puts
Call options by funds: $2.94M | Put options by funds: $1.45M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
2% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 45
4.16% less ownership
Funds ownership: 165.16% → 161% (-4.2%)
8% less funds holding
Funds holding: 159 → 147 (-12)
13% less capital invested
Capital invested by funds: $853M → $739M (-$114M)
32% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RRCP
Rip Road Capital Partners
Boston,
Massachusetts
|
+$5.2M |
| 2 |
LCM
Lakewood Capital Management
New York
|
+$5.09M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.45M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.53M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$9.33M |
| 2 |
Goldman Sachs
New York
|
-$5.98M |
| 3 |
Two Sigma Investments
New York
|
-$3.94M |
| 4 |
Millennium Management
New York
|
-$3.25M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.08M |
GDRX Hedge Fund Activity: Q2 2023 in Review
147 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q2 2023, worth a combined $739M — down 13% from $853M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of GDRX and 23 opened new positions — a net loss of 11 holders — while 45 trimmed existing stakes and 44 added.
The largest buyer was Rip Road Capital Partners, opening a new position worth an estimated $5.2M. The largest seller was Marshall Wace, exiting entirely with an estimated $9.33M sold.
- 147 institutional investors held GoodRx Holdings (GDRX) as of Q2 2023, down from 159 in Q1 2023.
- Funds reported $739M of GoodRx Holdings stock for Q2 2023, down 13% quarter-over-quarter.
- 23 funds opened new GoodRx Holdings positions in Q2 2023 and 34 closed out, a net change of -11 holders.
- The largest GoodRx Holdings buyer in Q2 2023 was Rip Road Capital Partners, an estimated $5.2M added.
- The largest GoodRx Holdings seller in Q2 2023 was Marshall Wace, an estimated $9.33M sold.
Based on aggregated 13F filings for Q2 2023.